期刊文献+

应用FISH技术检测嗜酸性粒细胞增多症PDGFRA基因异常表达 被引量:1

Detecting the Abnormal Expression of PDGFRA Gene in Eosinophilia by FISH
下载PDF
导出
摘要 本研究通过荧光原位杂交(FISH)检测,观察PDGFRA基因在嗜酸性粒细胞增多症中的异常表达情况。应用FISH技术和4q12三色重排探针,检测13例嗜酸性粒细胞增多患者PDGFRA基因的重排形式,同时选择15例正常对照用于确定4q12探针异常荧光信号的正常阈值。结果表明:13例患者中有1例纠正诊断为慢性粒细胞白血病,其余12例中有2例检出FIP1L1-PDGFRA(F/P)融合基因,检出率为17%,但本研究未发现累及PDGFRA基因的其他易位形式。结论:利用4q12三色探针的FISH检测可同时观察PDGFRA基因的多种易位情况,为嗜酸性粒细胞增多症的诊断以及治疗方案的选择提供重要信息。 This study was aimed to investigate the abnormal expression of PDGFRA gene in eosinophilia by FISH.Translocations of PDGFRA gene in 13 patients with eosinophilia were detected by using 4q12 three-color probe and FISH technology.Fifteen people were used as control to establish the normal cut-off value of fluorescence signal of PDGFRA.The results indicated that 1 out of 13 patients with eosinophilia was corrected and was diagnosed as CML.The fusion gene of FIP1L1-PDGFRA(F/P) was found in 2 patients and the positive rate of F/P fusion gene detected by probe 4q12 was 17% in the 12 patients with eosinophilia.Other translocation forms involving PDGFRA gene were not found.It is concluded that a variety of translocation forms of PDGFRA gene can be detected in patients with eosinophilia by using 4q12 three-color probe and FISH technology,which can provide important information for assessing diagnosis and treatment.
出处 《中国实验血液学杂志》 CAS CSCD 北大核心 2014年第5期1377-1380,共4页 Journal of Experimental Hematology
基金 首都健康培育项目(Z111107067311050)
关键词 嗜酸性粒细胞增多症 荧光原位杂交 PDGFRA基因 eosinophilia FISH PDGFRA gene
  • 相关文献

参考文献12

  • 1Cools J,DeAngelo DJ,Gotlib J,et al.A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome.N Engl J Med,2003;348(13):1201-1214.
  • 2Swerdlow SH,Campo E,Harris NL,et al.World Health Organization Classification of Tumors of Haematopoietic and Lymphoid Tissues.Lyon,France:IARC Press:2008.
  • 3姜孟孟,周敏航,高丽,丁一,徐媛媛,王莉莉,靖彧,王全顺,于力.多重巢式RT-PCR对骨髓增殖性肿瘤中PDGFRα融合基因的快速检测[J].中国实验血液学杂志,2011,19(6):1447-1449. 被引量:2
  • 4Fink SR,Belongie KJ,Paternoster SF,et al.Validation of a new three-color fluorescence in situ hybridization(FISH)method to detect CHIC2 deletion,FIP1L1/PDGFRA fusion and PDGFRA translocations.Leuk Res,2009;33(6):843-846.
  • 5荆源,方美云,姜凤,林樉,王芳婷.53例多发性骨髓瘤细胞遗传学研究[J].中国实验血液学杂志,2011,19(1):68-72. 被引量:4
  • 6Gotlib J,Cools J.Five years since the discover of the FIP1L1-PDGFRA:What we have learned about the fusion and other molecularly defined eosinophilias.Leukemia,2008;22:1999-2010.
  • 7Hochhaus A,le Coutre PD,Kantarjian HM,et al.Effect of the tyrosine kinase inhibitor nilotinib in patients with hypereosinophilic syndrome/chronic eosinophilicleukemia:analysis of the phase 2,openlabel,single-arm A2101 study.J Cancer Res Clin Oncol,2013.
  • 8Helbig G,Moskwa A,Hus M,et al.Clinical characteristics of patients with chronic eosinophilic leukaemia(CEL)harbouring FIP1L1-PDGFRA.Hematol Oncol,2010;28(2):93-97.
  • 9Klion AD.Eosinophilic myeloproliferative disorders.Hematology Am Soc Hematol Educ Program,2011:257-263.
  • 10曲士强,艾小菲,李承文,李庆华,徐泽锋,秦铁军,张悦,肖志坚.嗜酸性粒细胞增多患者的细胞遗传学和分子生物学特征的研究[J].中国实验血液学杂志,2012,20(5):1216-1220. 被引量:11

二级参考文献28

  • 1Calasanz MJ, Cigudosa JC, Odero MD, et al. Cytogenetics analysis of 280 patients with multiple myeloma and related disorder primary breakpoints and clinical correlations. Genes Chromosome Cancer, 1997;18(2) :84 -93.
  • 2Shaffer LG, Tommerup N. et al.ISCN: an international system for human cytogenetic nomenclature, karger S. Basel, 2005 : 1 - 117.
  • 3Liebisch P, Dohner H. Cytogenetics and molecular cytogenetics in multiple myeloma. Eur J Cancer,2006 ;42 ( 11 ) : 1520 - 1529.
  • 4Seong C, Delasalle K, Hayes K, et al. Prognostic value of cytogenetics in multiple myeloma. Br J Haematol, 1998 ; 101 ( 1 ) : 189 - 194.
  • 5Lai JL, Zandecki M, Mary JY, et al. Improved cytogenetics in multiple myeloma: a study of 151 patients including 117 patients at diagnosis. Blood, 1995 ; 85 (9) :2490 - 2497.
  • 6Facon T, Avet-Loiseau H, Guillerm G, et al. Chromosome 13 abnormalities identified by FISH analysis and serum beta 2- rnicroglobulin produce a powerful myeloma staging system for patients receiving high-dose therapy. Blood, 2001 ;97 (6) :1566 - 1571.
  • 7Smadja NV, Leroux D, Soulier J, et al. Further cytogenetic characterization of multiple myeloma conf'Lrms that 14q32 translocations are a vevy rare event in hyperdiploid cases. Genes Chromosomes Cancer, 2003 ;38 ( 3 ) :234 - 239.
  • 8Avet-Loiseau H, Gerson F, Magrangeas F, et al. Rearrangements of the c-myc oncogene are present in 15% of primary human multiple myeloma tumors. Blood, 2001 ; 98 ( 10 ) :3082 - 3086.
  • 9Pantou D, Rizou H, Tsarouha H, et al. Cytogenetic manifestations of multiple myeloma heterogeneity. Genes Chromosomes Cancer, 2005; 42(1) :44 -57.
  • 10Tefferi A,Vardiman JW.Classification and diagnosis of mye-loproliferative neoplasms:The 2008 World Health Organizationcriteria and point-of-care diagnostic algorithms.Leukemia,2008;22(1):14-22.

共引文献14

同被引文献4

  • 1李斌,张广森.伊马替尼治疗高嗜酸粒细胞综合征FIP1L1-PDGFRA融合基因变化的动态监测[J].中华血液学杂志,2006,27(2):125-126. 被引量:1
  • 2A. Pardanani,R.P. Ketterling,C.-Y. Li,M.M. Patnaik,A.P. Wolanskyj,M.A. Elliott,J.K. Camoriano,J.H. Butterfield,G.W. Dewald,A. Tefferi.FIP1L1-PDGFRA in eosinophilic disorders: Prevalence in routine clinical practice, long-term experience with imatinib therapy, and a critical review of the literature[J]. Leukemia Research . 2005 (8)
  • 3Cools J,DeAngelo DJ,Gotlib J,et al.A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. New England Journal of Medicine, The . 2003
  • 4C Walz,J Score,J Mix,D Cilloni,C Roche-Lestienne,R-F Yeh,J L Wiemels,E Ottaviani,P Erben,A Hochhaus,M Baccarani,D Grimwade,C Preudhomme,J Apperley,G Martinelli,G Saglio,N C P Cross,A Reiter.The molecular anatomy of the FIP1L1-PDGFRA fusion gene. Leukemia . 2008

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部